Recruiting studies: Established Atherosclerotic Cardiovascular Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic
NA · 1 location(s) · Rajaie Cardiovascular Medical and Research Center · NCT06541691 Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Establish
Phase 3 · 95 location(s) · Novartis Pharmaceuticals · NCT06813911 A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events i
Phase N/A · 90 location(s) · Amgen · NCT06295679 Pelacarsen Roll-over Extension Program
Phase 3 · 97 location(s) · Novartis Pharmaceuticals · NCT06875973 Effectiveness of Decision Support for Cardiovascular Risk Management in People With Cardiovascular Disease
NA · 8 location(s) · dr.Frank L.J. Visseren · NCT06871514 Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease
Phase 3 · 13 location(s) · Hospital do Coracao · NCT06930885 A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and
Phase 3 · 568 location(s) · Eli Lilly and Company · NCT07241390 A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a
Phase 3 · 1365 location(s) · AstraZeneca · NCT07000357 A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Ev
Phase 3 · 58 location(s) · Eli Lilly and Company · NCT07613294

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.